Therapy Areas: Infectious Diseases
GC Biopharma's BARYTHRAX receives Korean regulatory approval
10 April 2025 - South Korean biopharmaceutical company GC Biopharma announced on Wednesday that it has received approval from the Korean Ministry of Food and Drug Safety (MFDS) for its anthrax vaccine...
Seegene Inc developing fully automated PCR solution
10 April 2025 - South Korea-based molecular diagnostics company Seegene Inc announced on Wednesday it is advancing CURECA, a new system currently under development.The CURECA system is designed to str...
Oxford Nanopore and Cepheid form partnership to advance sequencing-based solutions for infectious diseases
9 April 2025 -

Molecular sensing technology company Oxford Nanopore Technologies plc (LSE: ONT) and molecular diagnostics company Cepheid announc...

bioMérieux receives CE-marking for LUMED APSS to support antimicrobial stewardship in Europe
7 April 2025 - French diagnostics company bioMérieux (Euronext Paris:BIM) announced on Monday that it has obtained CE-marking for LUMED APSS, a clinical decision support system designed to enha...
Ondine Biomedical's Steriwave technology reduces surgical site infections by 71% in NHS deployment
2 April 2025 - Nasal photodisinfection system provider Ondine Biomedical Inc (LON: OBI) on Wednesday announced successful results from the first NHS deployment of its Steriwave nasal decolonisation te...
AKAGERA Medicines completes first cohort in phase 1 SAD/MAD study of AKG-100
2 April 2025 - AKAGERA Medicines Inc, a biotech company developing novel lipid nanoparticle formulations of antibacterial drugs and mRNA vaccines to treat tuberculosis, avian flu, RSV and other infect...